gives too much play to lilly's view but still a good article.

and david I am / freedom center is a mindfreedom member btw, if you want 
to put this on the mfi website

Activist gagged for drug fact leak in Lilly case

NORTHAMPTON - A city man who co-founded a mental health advocacy group 
is among those drug giant Eli Lilly has sought to silence regarding 
documents leaked about Zyprexa, its bestselling drug for schizophrenia.

Will Hall, a member of the Freedom Center in Northampton - a group often 
critical of the pharmaceutical industry and that also offers support and 
holistic alternatives for people with mental illness - is one of 13 
people named in a gag order pursued by Lilly.

The order was granted in a federal court in New York Dec. 29 and renewed 
on Jan. 4. It forbids Hall and others from disseminating or facilitating 
the dissemination of internal Lilly documents Hall and others say prove 
that the corporation suppressed information about the side effects of 
Zyprexa and promoted so-called 'off-label' use.

The documents were originally obtained via subpoena by Jim Gottstein, an 
Alaskan lawyer, as part of a lawsuit involving Zyprexa. Lilly alleges 
that Gottstein then disseminated the documents to a dozen mental-health 
activists who are critical of the drug industry, including Hall.

Hall, reached in Portland, Ore., Thursday, where he is working with 
another mental health advocacy group, said he has seen the documents, 
and they show that Lilly knew Zyprexa could cause diabetes and that the 
company pushed the use of the drug for dementia, although it is not 
approved for such use. Such marketing is illegal.

Lilly strongly denies the accusations. A spokeswoman for the company 
said questions about Zyprexa are answered at A 
Lilly press release on the site says media reports have omitted several 
facts about the drug.

'From the day that Zyprexa was approved, the labeling provided to 
physicians identified the potentially clinically significant weight gain 
that was observed in more than half of all patients treated long-term 
with Zyprexa, as well as the diabetes-related adverse events observed in 
clinical trials,' an online Lilly response states.

In an email response, the Lilly spokeswoman, Carole Puls, wrote, 'The 
leaked documents - only a few hundred of the 11 million pages, so far as 
we can determine - have been carefully selected by the 'leakers' to tell 
a story that the 'leakers' want them to tell. These documents do not in 
any way represent an accurate view of Lilly company strategy or 
activities. What these individuals are not likely to show you is the 
millions of other pages of documents demonstrating how Lilly and its 
employees have worked to improve the lives of people with schizophrenia 
or bipolar disorder.'

As to the confidentiality of the documents, she wrote, 'The United 
States Supreme Court has held that there is no First Amendment right of 
access to confidential documents subject to a protective order in 

The Electronic Frontier Foundation, a digital-rights advocacy group, is 
now representing the anonymous person who posted the documents online. 
The current gag order expires Jan. 16.

'This is a real free speech issue,' Hall said. 'It's this chilling 
effect of trying to intimidate people from (getting this information).' 
He said he is concerned that local mental health professionals are using 
the drugs without accurate information about it.

A spokeswoman at the American Psychiatric Association said Friday that 
the group does not comment on specific drugs.

Hall, 40, moved to Northampton in 2000 after periods of hospitalization 
in New Hampshire and California for what was diagnosed as schizophrenia. 
He said he was coerced into taking psychiatric drugs and that these 
drugs didn't help him. He said he rejects the label of 'schizophrenic,' 
has been drug-free since 1992 and believes that alternative therapies, 
such as meditation, yoga, acupuncture and a better diet have helped him 
control what he calls his 'extreme states of consciousness.'

The Freedom Center, he said, is pro-choice on the issue of whether to 
take psychiatric drugs. Some of the members feel the drugs have helped 
them, while others choose not to take drugs, he said.

The results of clinical trials for Lilly products can be found on the 
company's online registry at

Zyprexa-discuss mailing list

Reply via email to